Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 20,12120,140 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Studies of the structural and functional basis of neuroblastoma drug resistance
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Neuroblastoma is the most common extracranial tumor of young children, and the five-year overall survival of children with high-risk disease is less than 5...

$335.6K
USD
Completed NON-SBIR/STTR RPGS
Impact of brain estrogens on cognition and brain aging in a non-human primate
NATIONAL CANCER INSTITUTE University of Massachusetts Amherst United States 2021 – 2025

SUMMARY Aromatase inhibitors (AIs) are drugs that inhibit estrogen synthesis and that are prescribed to prevent the recurrence of estrogen responsive breast cancers. However, AIs,...

$4.96M
USD
Completed NON-SBIR/STTR RPGS
The Impact of Aging on Prostate Cancer with Age-Related Disruption of Th17/Treg Axis
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2021 – 2025

Project Summary/Abstract: Prostate cancer (PCa) is particularly important in elderly men because of the high incidence and prevalence of disease and mortality in this group of pati...

$3.3M
USD
Completed NON-SBIR/STTR RPGS
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2025

Durable outcomes in subsets of solid cancer patients treated with immune checkpoint inhibitors (ICI) or adoptive cell transfer (ACT) immunotherapy has driven interest in gaining a...

$6.62M
USD
Completed NON-SBIR/STTR RPGS
Therapeutic Targeting Mitochondrial C1 Metabolism
NATIONAL CANCER INSTITUTE Wayne State University United States 2021 – 2025

ABSTRACT Metabolic reprogramming is an important hallmark of cancer. Of the altered metabolic pathways associated with malignancy, one-carbon (C1) metabolism is particularly notabl...

$5.84M
USD
Completed OTHER RESEARCH-RELATED
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Wilms tumor is the most common kidney cancer in children. High-risk patient groups continue to have dismal outcomes. The greatest predictor of a poor outco...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

Our data indicate that in select settings activation of acid sphingomyelinase (ASMase)/ceramide signaling in tumor endothelial cells by radiation and certain chemotherapies synergi...

$3.85M
USD
Completed NON-SBIR/STTR RPGS
A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2025

PROJECT SUMMARY Women at elevated risk for breast cancer should complete genetic counseling and may require more frequent screening or additional tests (e.g. breast magnetic resona...

$5.45M
USD
Completed NON-SBIR/STTR RPGS
A deubiquitination module controls Treg adaptation to tumor microenvironment
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2025

Project Summary: One of the recent advances in cancer treatment is the development of immunotherapy largely through targeting the checkpoint receptors. However, attempts at immunot...

$5.34M
USD
Completed NON-SBIR/STTR RPGS
Establishing smoke-free homes with families involved in child protective services: An effectiveness-implementation trial of an integrated program
NATIONAL CANCER INSTITUTE Georgia State University United States 2021 – 2025

Project Abstract Child exposure to secondhand smoke (SHS) is linked to multiple forms of cancer throughout the lifespan. Young children living in low-socioeconomic status household...

$6.13M
USD
Completed NON-SBIR/STTR RPGS
Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Project summary: This project aims to clinically translate hyperpolarized (HP) 13C pyruvate MRI as an innovative metabolic imaging approach for noninvasive prediction of renal tumo...

$6.03M
USD
Completed NON-SBIR/STTR RPGS
Tissue Damage-Driven Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Squamous cell carcinoma (SCC) is responsible for ~10% of total cancer mortality worldwide. SCC prognosis is context-dependent and does not seem to be determined by driver gene soma...

$3.39M
USD
Completed NON-SBIR/STTR RPGS
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2025

Gene silencing using small interfering RNA (siRNA) is a viable therapeutic approach but, limited in translation due to lack of effective delivery systems. Developing effective and...

$3.46M
USD
Completed NON-SBIR/STTR RPGS
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2025

PROJECT SUMMARY The incidence of esophageal adenocarcinoma (EAC) has risen 10-fold over the past half century and continues to have a dismal prognosis. Known modifiable risk factor...

$4.68M
USD
Completed NON-SBIR/STTR RPGS
Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2025

Project Summary Many long-term survivors of cancer experience progressive chemotherapy-induced cognitive impairment (CICI, commonly referred to as "chemobrain"). Importan...

$3.15M
USD
Completed NON-SBIR/STTR RPGS
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2025

PROJECT SUMMARY Our continued inability to develop selective therapies that prevent the emergence of disseminated breast tumor cells into lethal metastases necessitates new approac...

$3.82M
USD
Completed NON-SBIR/STTR RPGS
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2025

PROJECT SUMMARY Early detection of lung cancer among asymptomatic individuals is a priority for reducing mortality of the number one cancer killer worldwide. Most lung cancers are...

$6.25M
USD
Completed NON-SBIR/STTR RPGS
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2025

Though initially responsive to hormonal therapy, prostate cancer (PCa) invariably progresses to an incurable metastatic castration-resistant state (mCRPC). Additionally, the propor...

$3.94M
USD
Completed NON-SBIR/STTR RPGS
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2025

Our overarching hypothesis is that senescent stromal fibroblasts, especially if they elicit an inflammatory response, promote progression to lethal disease in men with prostate can...

$1.37M
USD
Completed TRAINING, INDIVIDUAL
Impact of the microbiome on chemotherapeutic outcomes
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Cytotoxic chemotherapeutic agents are a key component of cancer therapy, but they have unpredictable treatment responses and considerable treatment-related...

$539.7K
USD